
Librede is a synthetic biology company that uses biologically-based approaches to produce high value natural products with a focus on cannabinoids. Librede’s patented yeast-based cannabinoid production platform can provide therapeutic cannabinoids to diverse markets in an economically and environmentally sustainable way. Librede offers a low cost, efficient, modular platform for biosynthesis of any natural cannabinoid. Current agricultural based production requires large areas of land, fertilizers, pesticides, and large amounts of water. Librede’s system does not require large areas of land, it recycles the water that is used, uses less energy, and does not use any fertilizers or pesticides.
Librede was acquired by Lygos in 2020. Learn more here.
Graduated in 2015
Librede was acquired by Lygos in 2020. Learn more here.
Graduated in 2015
Graduated Companies
- Adaptix
- Aneeve
- Aneuvo
- Appia Bio
- Bluefin Foods
- CarbonBuilt
- Carbonics
- Charlot Biosciences
- CBD Research Institute
- Cellmic
- Concrete-AI
- Craytex
- CytoLumina
- DARTS Sciences
- Electronucleics
- EP Dynamics
- Ferrologix
- Gradient Orthodontics
- Horizon PV
- Inspira
- Inston
- InvVax
- Kelvi
- Keyssa
- Kythera Biopharmaceuticals
- Librede
- Lucendi
- Matrix Sensors, Inc.
- MAX BioPharma
- MediSens Wireless
- MicrobeDx
- MyoGene Bio
- Myst Therapeutics
- Nammi Therapeutics
- Nanoarmor, LLC.
- NanoClear
- NanoElectronic Imaging
- NanoH₂O
- Nanopixel Technologies
- National Institute of Cannabinoid Research (NICR)
- Nuvola Technology
- Octant
- Omega Biosystems
- Orchard Therapeutics
- Polyradiant
- Qwixel Therapeutics
- Restore Technologies
- Sardona Therapeutics
- SELFA
- Sixal
- Spectradyne
- Tempo Therapeutics
- TrueCath
- U-Defi
- Valerion Therapeutics
- Vivibaba
- Zenomics
- Back to Portfolio